Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain (“CINP”) ...
Reported positive data from the Phase II MAvERIC-Pilot study investigating the impact of CardiolRx™ administered to patients with symptomatic recurrent pericarditis; results support advancing to the ...
Highlights,Swiss National Bank adjusted its holdings in Perspective Therapeutics, Inc. during the fourth quarter.,Several ...
Corcept's relacorilant hits phase 3 trial success in ovarian cancer, lifting shares 90%. Click here to find out why I rate ...
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and neuropsychiatric disorders, today announced the enrollment of ...
Learn more about whether Corcept Therapeutics Incorporated or Zoetis Inc. is a better investment based on AAII's A+ Investor ...
Rapport Therapeutics focuses on developing specific small molecule therapies for CNS diseases. Check out my recommendation ...
Learn more about whether Corcept Therapeutics Incorporated or Haleon plc is a better investment based on AAII's A+ Investor ...
Study Finds on MSN6d
Why Women’s Pain Has Been Misunderstood For DecadesExplore the critical differences in how women's pain is processed and how tailored treatments can alleviate chronic pain.
Highlights,Commonwealth Equity Services LLC refines its position in Viking Therapeutics Inc.,Company operates within the ...
Virtual reality (VR) might be able to provide cancer patients significant pain relief, a new study says. A small group of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback